Taysha Gene Therapies Cash Flow Statement 2019-2024 | TSHA

Fifteen years of historical annual cash flow statements for Taysha Gene Therapies (TSHA).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
20232022202120202019
$-111.57$-166.01$-174.52$-60.01$0.00
$1.37$1.17$0.49$0.01$0.00
$55.19$57.93$28.32$29.38$0
$56.56$59.11$28.81$29.39$0
$0$0$0$0$0
$0$0$0$0$0
$-2.30$-7.80$14.49$1.96$0
$-9.44$35.65$-3.37$-6.58$0
$-18.01$18.52$28.67$-0.11$0.00
$-73.02$-88.39$-117.04$-30.73$0.00
$-3.87$-20.62$-15.30$-0.08$0.00
$-3.50$-4.25$-6.25$-9.00$0
$0$0$0$0$0.00
$0$0$0$0$0
$0$0$0$0$0
$0$0$0$0$0.00
$0.02$-0.06$0$0$0
$-7.35$-24.93$-21.55$-9.08$0.00
$-3.45$0$39.96$0$0
$0$0$0$0$0.00
$-3.45$0$39.96$0$0.00
$141$41.86$0$166$0
$141$41.86$0$291$0.00
$0$0$0$0$0.00
$-1.02$10.24$-0.87$0$0
$136$52.10$39.08$291$0.00
$56.02$-61.22$-99.51$251$0.00
$7.91$18.04$18.18$3.35$0
$0$0$0$0$0